Biogen (BIIB) Non-Current Assets (2009 - 2026)

Biogen (BIIB) has reported Non-Current Assets for 18 consecutive years, with $20.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets fell 0.56% year-over-year to $20.3 billion; the TTM figure through Mar 2026 stood at $81.4 billion (down 0.96% YoY), while the FY2025 annual figure was $20.5 billion, down 0.62% from the prior year.
• Non-Current Assets came in at $20.3 billion for Q1 2026 at Biogen, down from $20.5 billion in the prior quarter.
• The five-year high for Non-Current Assets was $21.5 billion in Q3 2024, with the low at $14.7 billion in Q2 2023.
• Average Non-Current Assets over 5 years is $18.4 billion, with a median of $19.8 billion recorded in 2024.
• Across the five-year window, Non-Current Assets dropped 11.26% in 2022 and jumped 35.38% in 2023, its largest moves.
• Year by year, Non-Current Assets stood at $14.8 billion in 2022, then surged by 35.38% to $20.0 billion in 2023, then advanced by 3.04% to $20.6 billion in 2024, then retreated by 0.62% to $20.5 billion in 2025, then retreated by 0.84% to $20.3 billion in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $20.3 billion, $20.5 billion, and $20.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.